Elena Gonzalez Rodriguez

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


77 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2012 | 2009 | 2007 | 2005 |
Prospective associations between breast feeding, metabolic health, inflammation and bone density in women with prior gestational diabetes mellitus.
Hebeisen I., Gonzalez Rodriguez E., Arhab A., Gross J., Schenk S., Gilbert L., Benhalima K., Horsch A., Quansah D.Y., Puder J.J., 2024/05/21. BMJ open diabetes research & care, 12 (3). Peer-reviewed.
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review.
Vendrami C., Shevroja E., Gonzalez Rodriguez E., Gatineau G., Elmers J., Reginster J.Y., Harvey N.C., Lamy O., Hans D., 2024/04. Journal of cachexia, sarcopenia and muscle, 15 (2) pp. 477-500. Peer-reviewed.
Relationship between dietary characteristics and heel quantitative ultrasound parameters in postmenopausal women from the OsteoLaus cohort.
Lanyan A., Marques-Vidal P., Métrailler A., Gonzalez Rodriguez E., Hans D., Shevroja E., Lamy O., 2024/01/18. Scientific reports, 14 (1) p. 1638. Peer-reviewed.
Effect of a prepartum and postpartum, complex interdisciplinary lifestyle and psychosocial intervention on metabolic and mental health outcomes in women with gestational diabetes mellitus (the MySweetheart trial): randomised, single centred, blinded, controlled trial.
Quansah D.Y., Gilbert L., Arhab A., Gonzalez-Rodriguez E., Hans D., Gross J., Lanzi S., Stuijfzand B., Lacroix A., Horsch A. et al., 2024. BMJ medicine, 3 (1) pp. e000588. Peer-reviewed.
 
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
Clifton Goldney D., Pelegrin C., Jerkovich F., Longobardi V., Gonzalez Rodriguez E., Zanchetta M.B., 2024/01. Osteoporosis international, 35 (1) pp. 165-171. Peer-reviewed.
Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
Métrailler A., Hans D., Lamy O., Gonzalez Rodriguez E., Shevroja E., 2023/08. Osteoporosis international, 34 (8) pp. 1401-1409. Peer-reviewed.
Maintenance of bone resorption markers in the low premenopausal range during the year following denosumab discontinuation is associated to bone density preservation. The ReoLaus study.
Liebich G., Lamy O., Aubry-Rozier B., Gonzalez-Rodriguez E., 2023/07. Bone, 172 p. 116764. Peer-reviewed.
Effets indésirables des traitements contre l’ostéoporose : comment les expliquer aux patient-e-s ? [Side effects of osteoporosis treatments: how to explain them to patients?]
Curraj E., Gonzalez Rodriguez E., 2023/04/19. Revue medicale suisse, 19 (823) pp. 746-751. Peer-reviewed.
L’intelligence artificielle a-t-elle un rôle dans la prise en charge de l’ostéoporose ? [Does artificial intelligence have a role in osteoporosis management?]
Vendrami C., Gatineau G., Shevroja E., Gonzalez Rodriguez E., Lamy O., Hans D., 2023/04/19. Revue medicale suisse, 19 (823) pp. 752-755. Peer-reviewed.
Quand penser à une maladie osseuse constitutionnelle ? [Constitutional diseases of bone: clinical flags]
Debrach A.C., Brégou A., Gonzalez Rodriguez E., Pejin Z., Kumps C., Craig A., Pavlidou D.C., Atallah I., 2023/04/19. Revue medicale suisse, 19 (823) pp. 766-769. Peer-reviewed.
Mastocytose systémique et impact osseux [Systemic mastocytosis and bone impact]
Vaucher M., Gonzalez Rodriguez E., Efthymiou A., Sagez J., 2023/03/22. Revue medicale suisse, 19 (819) pp. 591-595. Peer-reviewed.
The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial.
Papageorgiou M., Biver E., Mareschal J., Phillips N.E., Hemmer A., Biolley E., Schwab N., Manoogian ENC, Gonzalez Rodriguez E., Aeberli D. et al., 2023/02. Obesity, 31 Suppl 1 pp. 85-95. Peer-reviewed.
Ostéoporose : ce qui a changé en 2022 [Osteoporosis: what's new in 2022]
Gonzalez Rodriguez E., Debrach A.C., Lamy O., 2023/01/18. Revue medicale suisse, 19 (809-10) pp. 62-65. Peer-reviewed.
Marked weight loss on liraglutide 3.0 mg: Real-life experience of a Swiss cohort with obesity.
Santini S., Vionnet N., Pasquier J., Gonzalez-Rodriguez E., Fraga M., Pitteloud N., Favre L., 2023/01. Obesity, 31 (1) pp. 74-82. Peer-reviewed.
Intuitive Eating Behavior, Diet Quality and Metabolic Health in the Postpartum in Women with Gestational Diabetes.
Quansah D.Y., Schenk S., Gilbert L., Arhab A., Gross J., Marques-Vidal P.M., Gonzalez Rodriguez E., Hans D., Horsch A., Puder J.J., 2022/10/13. Nutrients, 14 (20) p. 4272. Peer-reviewed.
 
Correction to: Stopping Denosumab.
Lamy O., Stoll D., Aubry-Rozier B., Gonzalez Rodriguez E., 2022/10. Current osteoporosis reports, 20 (5) p. 363. Peer-reviewed.
Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: A nested study within a randomized placebo controlled trial.
Büchi A.E., Feller M., Netzer S., Blum M.R., Gonzalez Rodriguez E., Collet T.H., Del Giovane C., van Heemst D., Quinn T., Kearney P.M. et al., 2022/08. Bone, 161 p. 116404. Peer-reviewed.
The fracture predictive ability of lumbar spine BMD and TBS as calculated based on different combinations of the lumbar spine vertebrae.
Shevroja E., Mo Costabella F., Gonzalez Rodriguez E., Lamy O., Hans D., 2022/06/09. Archives of osteoporosis, 17 (1) p. 83. Peer-reviewed.
 
Trabecular Bone Score Reference Values for Children and Adolescents According to Age, Sex, and Ancestry.
Kalkwarf H.J., Shepherd J.A., Hans D., Gonzalez Rodriguez E., Kindler J.M., Lappe J.M., Oberfield S., Winer K.K., Zemel B.S., 2022/04. Journal of bone and mineral research, 37 (4) pp. 776-785. Peer-reviewed.
Association of adiposity evaluated by anthropometric, BIA, and DXA measures with cardiometabolic risk factors in nonobese postmenopausal women: the CoLaus/OsteoLaus cohort.
Stamm E., Marques-Vidal P., Rodriguez E.G., Vollenweider P., Hans D., Lamy O., 2022/01/24. Menopause, 29 (4) pp. 450-459. Peer-reviewed.
Ostéoporose [Osteoporosis]
Gonzalez Rodriguez E., Debrach-Schneider A.C., Lamy O., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 56-58. Peer-reviewed.
Long-term body composition improvement in post-menopausal women following bariatric surgery: a cross-sectional and case-control study.
Santini S., Vionnet N., Pasquier J., Suter M., Hans D., Gonzalez-Rodriguez E., Pitteloud N., Favre L., 2022/01/06. European journal of endocrinology, 186 (2) pp. 255-263. Peer-reviewed.
 
A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity.
Jreige M., Hall N., Becce F., Aubry-Rozier B., Gonzalez Rodriguez E., Schaefer N., Prior J.O., Nicod Lalonde M., 2022. Frontiers in medicine, 9 p. 1050854. Peer-reviewed.
Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema.
Buso G., Favre L., Vionnet N., Gonzalez-Rodriguez E., Hans D., Puder J.J., Dubath C., Eap C.B., Raffoul W., Collet T.H. et al., 2022. Obesity facts, 15 (6) pp. 762-773. Peer-reviewed.
 
Quantitative Ultrasound (QUS) in the Management of Osteoporosis and Assessment of Fracture Risk: An Update.
Hans D., Métrailler A., Rodriguez E.G., Lamy O., Shevroja E., 2022. Advances in experimental medicine and biology, 1364 pp. 7-34. Peer-reviewed.
Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
Vendrami C., Marques-Vidal P., Gonzalez Rodriguez E., Hans D., Waeber G., Lamy O., 2022/01. Osteoporosis international, 33 (1) pp. 195-204. Peer-reviewed.
 
Long-term effect of bariatric surgery on body composition in post-menopausal women
Santini S., Vionnet N., Suter M., Pasquier J., Hans D., Pitteloud N., Gonzalez-Rodriguez E., Favre L., 2021/12. pp. S562 dans Clinical Nutrition ESPEN.
 
Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation: A Report of Two Cases.
Anagnostis P., Paschou S.A., Gonzalez-Rodriguez E., Potoupnis M., Tsiridis E., Lamy O., Goulis D.G., 2021/12/01. Journal of clinical rheumatology, 27 (8S) pp. S581-S584. Peer-reviewed.
Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.
Gonzalez Rodriguez E., Marques-Vidal P., Aubry-Rozier B., Papadakis G., Preisig M., Kuehner C., Vollenweider P., Waeber G., Hans D., Lamy O., 2021/11. Calcified tissue international, 109 (5) pp. 499-509. Peer-reviewed.
Vitamine D et grossesse [Vitamin D and pregnancy]
Eggel-Hort B., Maisonneuve E., Gonzalez Rodriguez E., Baud D., 2021/10/20. Revue medicale suisse, 17 (755) pp. 1774-1778. Peer-reviewed.
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases.
Burckhardt P., Faouzi M., Buclin T., Lamy O., The Swiss Denosumab Study Group, 2021/09. Journal of bone and mineral research, 36 (9) pp. 1717-1728. Peer-reviewed.
Dépistage et prise en charge de la sarcopénie au cabinet [Screening and management of sarcopenia by the general practitioner]
Vendrami C., Gonzalez Rodriguez E., 2021/04/21. Revue medicale suisse, 17 (735) pp. 770-773. Peer-reviewed.
Vers un rapport de santé osseuse individualisé centré sur le patient - Les paramètres osseux et les possibilités de traite [Towards an individualized bone health report focused on the patient - Bone parameters and treatment options]
Shevroja E., Lamy O., Gonzalez Rodriguez E., Hans D., 2021/04/21. Revue medicale suisse, 17 (735) pp. 774-779. Peer-reviewed.
The Effects of Time-Restricted Eating versus Standard Dietary Advice on Weight, Metabolic Health and the Consumption of Processed Food: A Pragmatic Randomised Controlled Trial in Community-Based Adults.
Phillips N.E., Mareschal J., Schwab N., Manoogian ENC, Borloz S., Ostinelli G., Gauthier-Jaques A., Umwali S., Rodriguez E.G., Aeberli D. et al., 2021/03/23. Nutrients, 13 (3) p. 1042. Peer-reviewed.
 
Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
Tsourdi E., Zillikens M.C., Meier C., Body J.J., Gonzalez Rodriguez E., Anastasilakis A.D., Abrahamsen B., McCloskey E., Hofbauer L.C., Guañabens N. et al., 2021/01/31. The Journal of clinical endocrinology and metabolism, 106 (1) pp. 264–281. Peer-reviewed.
Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
Camponovo C., Aubry-Rozier B., Lamy O., Gonzalez Rodriguez E., 2020/12. Osteoporosis international, 31 (12) pp. 2485-2491. Peer-reviewed.
Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252).
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/06. Journal of bone oncology, 22 p. 100294. Peer-reviewed.
 
Increased Risk of Multiple Spontaneous Vertebral Fractures at Denosumab Discontinuation Must Be Taken Into Account.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/05/10. Journal of clinical oncology, 38 (14) pp. 1641-1642. Peer-reviewed.
Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.
Lanyan A., Marques-Vidal P., Gonzalez-Rodriguez E., Hans D., Lamy O., 2020/05. Osteoporosis international, 31 (5) pp. 875-886. Peer-reviewed.
 
OsteoLaus: raisons d’être et premiers résultats []
Shevroja E., Hans D., Aubry-Rozier B., Gonzalez-Rodriguez E., Lamy O., 2020/01. Praxis, 109 (1) pp. 19-22. Peer-reviewed.
 
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/01. Breast cancer research and treatment, 179 (1) pp. 153-159. Peer-reviewed.
 
Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study.
Gonzalez Rodriguez E., Stuber M., Del Giovane C., Feller M., Collet T.H., Löwe A.L., Blum M.R., van Vliet N.A., van Heemst D., Kearney P.M. et al., 2020/01/01. The Journal of clinical endocrinology and metabolism, 105 (1). Peer-reviewed.
 
Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.
Shevroja E., Aubry-Rozier B., Hans G., Rodriguez E.G., Stoll D., Lamy O., Hans D., 2019/12. Journal of bone and mineral research, 34 (12) pp. 2229-2237. Peer-reviewed.
 
Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et al.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Lamy O., 2019/10. Arthritis & rheumatology, 71 (10) pp. 1770-1771. Peer-reviewed.
The Metabolic Benefits of Menopausal Hormone Therapy Are Not Mediated by Improved Nutritional Habits. The OsteoLaus Cohort.
Papadakis G.E., Hans D., Gonzalez Rodriguez E., Vollenweider P., Waeber G., Marques-Vidal P., Lamy O., 2019/08/16. Nutrients, 11 (8). Peer-reviewed.
 
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
Gonzalez Rodriguez E., Lamy O., 2019/08/01. The Journal of clinical endocrinology and metabolism, 104 (8) pp. 3535-3536. Peer-reviewed.
 
Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
Lamy O., Fernández-Fernández E., Monjo-Henry I., Stoll D., Aubry-Rozier B., Benavent-Núñez D., Aguado P., Gonzalez-Rodriguez E., 2019/05. Osteoporosis international, 30 (5) pp. 1111-1115. Peer-reviewed.
 
Denosumab in early-stage breast cancer.
Gonzalez Rodriguez E., Aubry-Rozier B., Stoll D., Lamy O., 2019/05. The Lancet. Oncology, 20 (5) pp. e233. Peer-reviewed.
 
Comment gérer l’effet rebond à l’arrêt du dénosumab et éviter les fractures vertébrales multiples ? [How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]
Gonzalez Rodriguez E., Lamy O., Aubry-Rozier B., Stoll D., Uebelhart B., 2019/04/17. Revue medicale suisse, 15 (647) pp. 831-835. Peer-reviewed.
 
Que faire face à une fracture vertébrale ostéoporotique ? [What can we do at the discovery of an osteroporotic vertebral fracture ?]
Brulhart D., Stoll D., Gonzalez Rodriguez E., Aubry-Rozier B., 2019/04/17. Revue medicale suisse, 15 (647) pp. 815-820. Peer-reviewed.
 
Traitement hormonal de la ménopause : effets osseux et sur la composition corporelle [Menopausal hormone therapy. Effects on bone and body composition]
Papadakis G., Gonzalez Rodriguez E., Marques-Vidal P., Hans D., Vollenweider P., Waeber G., Lamy O., 2019/04/17. Revue medicale suisse, 15 (647) pp. 836-839. Peer-reviewed.
 
Hepatosplenomegaly, pneumopathy, bone changes and fronto-temporal dementia: Niemann-Pick type B and SQSTM1-associated Paget's disease in the same individual.
Voinea C., Gonzalez Rodriguez E., Beigelman-Aubry C., Leroy V., Aubry-Rozier B., Campos-Xavier B., Ballhausen D., Lazor R., Barbey F., Bonafé L. et al., 2019/03. Journal of bone and mineral metabolism, 37 (2) pp. 378-383. Peer-reviewed.
 
Stopping Denosumab.
Lamy O., Stoll D., Aubry-Rozier B., Rodriguez E.G., 2019/02. Current osteoporosis reports, 17 (1) pp. 8-15. Peer-reviewed.
 
Fractures vertébrales multiples à l’arrêt du denosumab: comment les éviter? [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]
Lamy O., Gonzalez Rodriguez E., Stoll D., Aubry-Rozier B., Livio F., 2018/06. Praxis, 107 (12) pp. 649-654. Peer-reviewed.
Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort.
Papadakis G.E., Hans D., Rodriguez E.G., Vollenweider P., Waeber G., Marques-Vidal P., Lamy O., 2018/05/01. The Journal of clinical endocrinology and metabolism, 103 (5) pp. 1948-1957. Peer-reviewed.
 
Underestimation of Vertebral Fractures After Denosumab Discontinuation.
Lamy O., Gonzalez-Rodriguez E., 2018/03. Journal of bone and mineral research, 33 (3) p. 547. Peer-reviewed.
Improving cardiometabolic and mental health in women with gestational diabetes mellitus and their offspring: study protocol for <i>MySweetHeart Trial</i>, a randomised controlled trial.
Horsch A., Gilbert L., Lanzi S., Gross J., Kayser B., Vial Y., Simeoni U., Hans D., Berney A., Scholz U. et al., 2018/02/27. BMJ open, 8 (2) pp. e020462. Peer-reviewed.
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
Aubry-Rozier B., Stoll D., Gonzalez Rodriguez E., Hans D., Prudent V., Seuret A., Farron A., Lamy O., 2018. Swiss medical weekly, 148 pp. w14579. Peer-reviewed.
Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation.
Gonzalez-Rodriguez E., Stoll D., Lamy O., 2018. Case reports in rheumatology, 2018 p. 5432751. Peer-reviewed.
 
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women.
Lamy O., Aubry-Rozier B., Gonzalez-Rodriguez E., 2017/12/19. Annals of internal medicine, 167 (12) pp. 900-901. Peer-reviewed.
 
Administration de fer, hypophosphatémie et ostéomalacie []
Aubry-Rozier B., Stoll D., Rodriguez Gonzalez E., 2017/09/27. Revue medicale suisse, 13 (576) p. 1665. Peer-reviewed.
 
High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study.
Gonzalez Rodriguez E., Lamy O., Stoll D., Metzger M., Preisig M., Kuehner C., Vollenweider P., Marques-Vidal P., Waeber G., Aubry-Rozier B. et al., 2017/07/01. The Journal of clinical endocrinology and metabolism, 102 (7) pp. 2628-2636. Peer-reviewed.
 
Chirurgie surrénalienne : la multidisciplinarité est obligatoire [Adrenal surgery : Multidisciplinarity is mandatory]
Matthey Gié M.L., Nicod Lalonde M., Gonzalez Rodriguez E., Demartines N., Matter M., 2017/06/14. Revue medicale suisse, 13 (567) pp. 1253-1257. Peer-reviewed.
 
Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
Lamy O., Gonzalez-Rodriguez E., Aubry-Rozier B., 2017/06/01. The Journal of clinical endocrinology and metabolism, 102 (6) p. 2112. Peer-reviewed.
 
Bilan phosphocalcique perturbé dans le cadre d’une fragilité osseuse : des clés pour le praticien [Phosphocalcic anomalies and bone fragility keys for the general practitioner]
Aubry-Rozier B., Stoll D., Gonzalez-Rodriguez E., 2017/04/19. Revue medicale suisse, 13 (559) pp. 838-843. Peer-reviewed.
 
Dénosumab en routine clinique: précautions à prendre avant, pendant et après [Denosumab in clinical practice : beware before, during and after]
Lamy O., Gonzalez-Rodriguez E., Stoll D., Aubry-Rozier B., 2017/04/19. Revue medicale suisse, 13 (559) pp. 863-866. Peer-reviewed.
 
Response to the Letter by Trovas.
Lamy O., Gonzalez-Rodriguez E., Aubry-Rozier B., 2017/04/01. The Journal of clinical endocrinology and metabolism, 102 (3) p. 1087. Peer-reviewed.
 
The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
Padlina I., Gonzalez-Rodriguez E., Hans D., Metzger M., Stoll D., Aubry-Rozier B., Lamy O., 2017/03. Osteoporosis international, 28 (3) pp. 909-915. Peer-reviewed.
The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
Papadakis G., Hans D., Gonzalez-Rodriguez E., Vollenweider P., Waeber G., Marques-Vidal P.M., Lamy O., 2016/12. The Journal of clinical endocrinology and metabolism, 101 (12) pp. 5004-5011. Peer-reviewed.
 
Ostéoporose chez les femmes ménopausées entre 40 et 65 ans : algorithme pour le gynécologue [Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist]
Surbone A., Vulliemoz N., Gonzalez-Rodriguez E., Chatelain J.P., Lamy O., 2016/10/26. Revue medicale suisse, 12 (536) pp. 1811-1815. Peer-reviewed.
 
Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report.
Lamy O., Gonzalez-Rodriguez E., Stoll D., Hans D., Aubry-Rozier B., 2016/10/12. The Journal of clinical endocrinology and metabolism, 102 (2) pp. 354-358. Peer-reviewed.
 
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
Aubry-Rozier B., Gonzalez-Rodriguez E., Stoll D., Lamy O., 2016/05. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27 (5) pp. 1923-1925. Peer-reviewed.
Imagerie par DXA: le couteau suisse multifonction? [DXA imaging: the multifunction Swiss army knife?]
Gonzalez Rodriguez Elena, Lamy Olivier, Hans Didier, Favre Lucie, Pralong François, 2015. Revue Médicale Suisse, 11 (466) pp. 645-650. Peer-reviewed.
The glucocorticoid-induced leucine zipper (gilz/tsc22d3-2) gene locus plays a crucial role in male fertility.
Suarez P.E., Rodriguez E.G., Soundararajan R., Mérillat A.M., Stehle J.C., Rotman S., Roger T., Voirol M.J., Wang J., Gross O. et al., 2012. Molecular Endocrinology, 26 (6) pp. 1000-1013.
 
Effects of mineralocorticoid and K+ concentration on K+ secretion and ROMK channel expression in a mouse cortical collecting duct cell line.
Fodstad H., Gonzalez-Rodriguez E., Bron S., Gaeggeler H., Guisan B., Rossier B.C., Horisberger J.D., 2009. American Journal of Physiology. Renal Physiology, 296 (5) pp. F966-F975.
 
IGF-1 vs insulin: respective roles in modulating sodium transport via the PI-3 kinase/Sgk1 pathway in a cortical collecting duct cell line
Gonzalez-Rodriguez E., Gaeggeler H. P., Rossier B. C., 2007/01. Kidney International, 71 (2) pp. 116-25. Peer-reviewed.
 
Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line
Gaeggeler H. P., Gonzalez-Rodriguez E., Jaeger N. F., Loffing-Cueni D., Norregaard R., Loffing J., Horisberger J. D., Rossier B. C., 2005/04. Journal of the American Society of Nephrology, 16 (4) pp. 878-91.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University